646
I. Yavari et al.
(2H, m, CH), 7.76–7.81 (1H, m, CH), 7.98 (1H, d,
3JHH = 8 Hz, CH), 8.26–8.32 (1H, m, CH) ppm; 13C
NMR (CDCl3): d = 14.3 (Me), 45.4 (CH2), 61.4 (CH2O),
112.8 (C), 117.0 (CH), 119.3 (CH), 124.3 (CH), 125.4
(2CH), 127.3 (CH), 127.6 (CH), 127.7 (C), 129.0 (2CH),
130.1 (C), 134.0 (C), 134.2 (CH), 134.3 (CH), 134.4 (C),
139.0 (C), 148.2 (C–O), 154.3 (C–O), 167.2, 182.0, 182.0
(3C=O) ppm.
(CDCl3): d = 1.15 (3H, t, 3JHH = 7.1 Hz, Me), 1.35 (3H, t,
3
3JHH = 7.1 Hz, Me), 3.60 (3H, d, JHP = 11.1 Hz, MeO),
3
3.65 (3H, d, JHP = 11.1 Hz, MeO), 4.07-4.38 (5H, m,
CH2O, CH), 4.78 (1H, dd, 3JHH = 11.8 Hz, 3JHP = 6.7 Hz,
CH), 7.79-7.86 (4H, m, CH), 8.28-8.35 (2H, m, CH), 12.95
(1H, s, OH) ppm; 13C NMR (CDCl3): d = 14.3 (Me), 14.4
1
2
(Me), 46.2 (d, JCP = 130.0 Hz, CH), 46.3 (d, JCP
=
2
4.0 Hz, CH), 53.3 (d, JPC = 6.7 Hz, MeO), 53.7 (d,
2JPC = 7.2 Hz, MeO), 61.3 (CH2O), 62.2 (CH2O), 117.3
(C), 122.0 (CH), 127.2 (CH), 127.7 (CH), 127.8 (CH), 133.6
(C), 134.1 (C), 134.3 (CH), 135.2 (CH), 136.7 (C), 152.7
(C–O), 155.6 (C–O), 168.7 (d, 2JCP = 6.9 Hz, C=O), 171.4
(d, 3JCP = 20.9 Hz, C=O), 181.9 (C=O), 189.5 (C=O) ppm;
31P NMR (CDCl3): d = 22.71 ppm.
General procedure for the preparation of compounds
7 and 8
To a stirred solution of trialkyl phosphite (1 mmol) and
0.44 g of alizarin (2 mmol) in 5 cm3 of toluene was added
dropwise a mixture of the dialkyl acetylenedicarboxylate
(1 mmol) in 2 cm3 of toluene at r.t. The reaction mixture
was then refluxed for 24 h. The precipitate (compound 8)
was filtered and washed with cold Et2O. Then, the mother
liquid was evaporated under reduced pressure to give a
residue, which was separated on silica gel column chro-
matography (Merck 230–400 mesh) using hexane-AcOEt
(1:1) as eluent to afford compound 7.
Diethyl 2-(dimethoxyphosphoryl)-3-(9,10-dihydro-1-
hydroxy-9,10-dioxoanthracen-2-yloxy)butanedioate
(7c, C24H25O11P)
Yellow powder; yield: 0.34 g (67%); m.p.: 130–132 °C; UV
(EtOH, 95%): kmax (e) = 415 (2,990) nm (mol-1 cm2); IR
(KBr): vꢀ = 1,738 (C=O), 1,265 (P=O) cm-1; EI–MS:
m/z = 520 (M?, 5), 491 (100), 293 (33), 240 (55), 224
(15), 167 (9), 137 (7), 45 (80), 29 (65); 1H NMR (CDCl3):
3
Dimethyl 2-(dimethoxyphosphoryl)-3-(9,10-dihydro-1-
hydroxy-9,10-dioxoanthracen-2-yloxy)butanedioate
(7a, C22H21O11P)
d = 1.14 (3H, t, JHH = 7.1 Hz, Me), 1.46 (3H, t,
3JHH = 7.1 Hz, Me), 3.65 (3H, s, MeO), 3.87 (3H, s,
MeO), 3.88-4.10 (3H, m, CH2O, CH), 4.29–4.63 (2H, m,
3
3
Yellow powder; yield: 0.33 g (67%); m.p.: 137–139 °C; UV
(EtOH, 95%): kmax (e) = 413 (2,350) nm (mol-1 cm2); IR
(KBr): vꢀ = 1,739 (C=O), 1,273 (P=O) cm-1; EI–MS:
m/z = 492 (M?, 3), 477 (9), 463 (100), 249 (29), 240 (51),
CH2O), 4.75 (1H, dd, JHH = 11.6 Hz, JHP = 6.2 Hz,
CH), 7.79–7.86 (4H, m, CH), 8.28–8.34 (2H, m, CH), 12.98
(1H, s, OH) ppm; 13C NMR (CDCl3): d = 14.3 (Me), 14.4
1
2
(Me), 46.2 (d, JCP = 131.0 Hz, CH), 46.3 (d, JCP
4.1 Hz, CH), 53.0 (MeO), 53.4 (MeO), 62.8 (d,
=
1
224 (14), 167 (10), 132 (8), 109 (7), 31 (55); H NMR
3
2
(CDCl3): d = 3.55 (3H, d, JHP = 11.1 Hz, MeO), 3.65
2JPC = 6.2 Hz, CH2O), 63.3 (d, JPC = 6.9 Hz, CH2O),
(3H, d, 3JHP = 11.1 Hz, MeO), 3.88 (3H, s, MeO), 4.06 (1H,
117.5 (C), 122.1 (CH), 127.2 (CH), 127.7 (CH), 127.8 (CH),
133.5 (C), 134.1 (C), 134.3 (CH), 135.3 (CH), 136.3 (C),
152.5 (C–O), 155.5 (C–O), 169.4 (d, 2JCP = 6.7 Hz, C=O),
3
2
dd, JHH = 11.6 Hz, JHP = 21.2 Hz, CH), 4.14 (3H, s,
MeO), 4.75 (1H, dd, 3JHH = 11.6 Hz, 3JHP = 6.4 Hz, CH),
7.80-7.84 (4H, m, CH), 8.27-8.39 (2H, m, CH), 12.95 (1H, s,
3
171.5 (d, JCP = 21.2 Hz, C=O), 181.7 (C=O), 189.4
(C=O) ppm; 31P NMR (CDCl3): d = 22.69 ppm.
1
OH) ppm; 13C NMR (CDCl3): d = 45.9 (d, JCP
=
2
130.4 Hz, CH), 46.4 (d, JCP = 4.0 Hz, CH), 53.0 (MeO),
Diethyl 2-(diethoxyphosphoryl)-3-(9,10-dihydro-1-
hydroxy-9,10-dioxoanthracen-2-yloxy)butanedioate
(7d, C26H29O11P)
2
53.2 (MeO), 53.8 (d, JPC = 7.77 Hz, MeO), 54.2 (d,
2JPC = 6.21 Hz, MeO), 117.4 (C), 122.2 (CH), 127.2 (CH),
127.7 (CH), 127.8 (CH), 133.6 (C), 134.1 (C), 134.3 (CH),
135.2 (CH), 136.3 (C), 152.5 (C–O), 155.5 (C–O), 169.3 (d,
Yellow powder; yield: 0.36 g (65%); m.p.: 127–125 °C; UV
(EtOH, 95%): kmax (e) = 414 (3,100) nm (mol-1 cm2); IR
(KBr): vꢀ = 1,734 (C=O), 1,255 (P=O) cm-1; EI–MS:
m/z = 548 (M?, 7), 519 (100), 276 (26), 251 (15), 240
(56), 178 (11), 137 (8), 146 (9), 45 (87), 29 (63); 1H NMR
(CDCl3): d = 1.11 (3H, t, 3JHH = 7.1 Hz, Me), 1.21 (3H, t,
3JHH = 7.1 Hz, Me), 1.33 (3H, t, 3JHH = 7.1 Hz, Me), 1.50
(3H, t, 3JHH = 7.1 Hz, Me), 3.78-4.22 (5H, m, CH2O, CH),
3
2JCP = 6.0 Hz, C=O), 171.8 (d, JCP = 21.0 Hz, C=O),
181.8 (C=O), 189.4 (C=O) ppm; 31P NMR (CDCl3):
d = 22.47 ppm.
Diethyl 2-(dimethoxyphosphoryl)-3-(9,10-dihydro-
1-hydroxy-9,10-dioxoanthracen-2-yloxy)butanedioate
(7b, C24H25O11P)
3
Yellow powder; yield: 0.34 g (67%); m.p.: 145–148 °C; UV
(EtOH, 95%): kmax (e) = 412 (2,455) nm (mol-1 cm2); IR
(KBr): vꢀ = 1,740 (C=O), 1,275 (P=O) cm-1; EI–MS:
m/z = 520 (M?, 8), 505 (11), 491 (100), 276 (30), 251
(14), 240 (50), 178 (10), 146 (7), 109 (8), 31 (56); 1H NMR
4.33 (2H, q, JHH = 7.1 Hz, CH2O), 4.43 (2H, q,
3
3JHH = 7.1 Hz, CH2O), 4.79 (1H, dd, JHH = 11.7 Hz,
3JHP = 6.3 Hz, CH), 7.77–7.87 (4H, m, CH), 8.25–8.37
(2H, m, CH), 12.98 (1H, s, OH) ppm; 13C NMR (CDCl3):
d = 14.3 (Me), 14.4 (Me), 15.0 (Me), 15.0 (Me), 46.2 (d,
123